March 2010. Volume 6. Number 1

Celiac patients may have lower response to hepatitis B vaccination than healthy subjects

 
 
 
 
 
 
 
 
 
 
Rating: 5 (1 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies?. Vaccine 2009; 27: 6030-3
Reviewers: Bonillo Perales A1, Ortega Páez E2.
1Hospital Torrecárdenas. Almería. España.
2CS Maracena. Distrito metropolitano. Granada. España.
Correspondence: Antonio Bonillo Perales. Email: abonillop@ono.com
Reception date: 25/02/2010
Acceptance date: 08/03/2010
Publication date: 25/03/2010

Abstract

Authors’ conclusions: celiac disease patients are less responders to hepatitis B vaccination than healthy children

Reviewers’ commentary: celiac patients may have a decreased response to hepatitis B vaccination, but before recommending a systematic assessment of their seroprotection status and revaccinationwe should have more methodologically powerful studies.

How to cite this article

Ortega Páez E, Bonillo Perales A. Los pacientes celíacos podrían tener menor respuesta a la vacunación de la hepatitis B que los sujetos sanos. Evid Pediatr. 2010;6:16.

AVC | Critically appraised articles

Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies?. Vaccine 2009; 27: 6030-3
Reviewers: Bonillo Perales A1, Ortega Páez E2.
1Hospital Torrecárdenas. Almería. España.
2CS Maracena. Distrito metropolitano. Granada. España.
Correspondence: Antonio Bonillo Perales. Email: abonillop@ono.com
Reception date: 25/02/2010
Acceptance date: 08/03/2010
Publication date: 25/03/2010

How to cite this article

Ortega Páez E, Bonillo Perales A. Los pacientes celíacos podrían tener menor respuesta a la vacunación de la hepatitis B que los sujetos sanos. Evid Pediatr. 2010;6:16.

References

  1. Fasano, A, Berti, I, Gerarduzzi, T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med. 2003;163:286.
  2. Cilleruelo Pascual E, Román Riechmann E, Jiménez Jiménez J, et al. Enfermedad celíaca silente: explorando el iceberg en población escolar. An Esp Pediatr. 2002;57:321-6.
  3. Riestra S, Fernández E, Rodrigo L et al. Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening. Scand J Gastroenterol. 2000;35:398-402.
  4. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA Class II associations with hepatitis B clearance and vaccine nonresponsiveness. Hepatology. 2005;41:1383-90.
  5. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35:1368-75.
  6. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005; 142:333-41.
  7. Prak SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, Levine J.Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44:431-5.
  8. Ahishali E, Boztas G, Akyuz F, Ibrisim D, Poturoglu S, Pinarbasi B, Ozdil S, Mungan Z.Response to hepatitis B vaccination in patients with celiac disease.Dig Dis Sci. 2008;53:2156-9.
  9. Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivano?lu E, Eksioglu-Demiralp E.The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol. 2009 Jul 4. [Epub ahead of print]
25/03/2010

Linked Comment